German chemical and pharma major Bayer today expressed confidence that it would secure fair trade regulator, the Competition Commission of India’s, nod by April or May for the US$66 billion acquisition of US-based biotech major Monsanto.
India is one of the 30 countries whose approval is needed for the merger to go through. As many as 14 countries have already approved the merger.
The company has secured one approval in the US, while one more is pending. The European Union’s clearance is also awaited.
“We are working with the regulator. We are confident of getting the CCI approval,” said Richard van der Merwe, the senior Bayer representative of South Asia.
Full Content: The Economic Times
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Johnson & Johnson to Acquire Intra-Cellular Therapies in $14.6 Billion Deal
Jan 14, 2025 by
CPI
EU Regulators Reevaluate Big Tech Cases as Trump Prepares to Take Office
Jan 14, 2025 by
CPI
Supreme Court Declines to Hear Realtors’ Appeal, DOJ Antitrust Probe Moves Forward
Jan 13, 2025 by
CPI
Commerzbank Chairman Doubts Amicable Merger with UniCredit After Stake Acquisition
Jan 13, 2025 by
CPI
Senator Warren Presses HUD Nominee on Rent Price-Fixing
Jan 13, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – CRESSE Insights
Dec 19, 2024 by
CPI
Effective Interoperability in Mobile Ecosystems: EU Competition Law Versus Regulation
Dec 19, 2024 by
Giuseppe Colangelo
The Use of Empirical Evidence in Antitrust: Trends, Challenges, and a Path Forward
Dec 19, 2024 by
Eliana Garces
Some Empirical Evidence on the Role of Presumptions and Evidentiary Standards on Antitrust (Under)Enforcement: Is the EC’s New Communication on Art.102 in the Right Direction?
Dec 19, 2024 by
Yannis Katsoulacos
The EC’s Draft Guidelines on the Application of Article 102 TFEU: An Economic Perspective
Dec 19, 2024 by
Benoit Durand